October 15, 2007 - Phenomix Hires John Crawford As Chief Financial Officer and Appoints Arlene Morris to Board of Directors
September 11, 2007 - Phenomix Initiates Phase 2b Clinical Trial Of PHX1149 For Type 2 Diabetes; Will Present PHX1149 Data At EASD
July 19, 2007 - Phenomix Appoints James Harper and William Harris to Board of Directors
March 8, 2007 - Phenomix Completes $55 Million Series C Financing
March 5, 2007 - Phenomix Completes Phase 2A Clinical Trial Diabetes Drug Is Efficacious And Well Tolerated
